Sponsored Projects Administration

Big pharma increasingly opening up big data for clinical trial analytics

Published August 08, 2014 by OSP


Big pharma hopes to speed the process of bringing products to fruition while flagging dead ends and patient safety risks more quickly and efficiently. With billions of dollars on the line each year and a growing thirst for transparency turning data hoarders into the bad guys, it seems like it’s worth a try.

Read More